Literature DB >> 28492127

Obstructive pulmonary disease in patients with previous tuberculosis: Pathophysiology of a community-based cohort.

Brian W Allwood1, Rencia Gillespie, Maya Galperin-Aizenberg, Mary Bateman, Helena Olckers, Luis Taborda-Barata, Gregory L Calligaro, Qonita Said-Hartley, Richard Van Zyl-Smit, Christopher B Cooper, Eva Van Rikxoort, Jonathan Goldin, Nulda Beyers, Eric D Bateman.   

Abstract

BACKGROUND: An association between chronic airflow limitation (CAL) and a history of pulmonary tuberculosis (PTB) has been confirmed in epidemiological studies, but the mechanisms responsible for this association are unclear. It is debated whether CAL in this context should be viewed as chronic obstructive pulmonary disease (COPD) or a separate phenotype.
OBJECTIVE: To compare lung physiology and high-resolution computed tomography (HRCT) findings in subjects with CAL and evidence of previous (healed) PTB with those in subjects with smoking-related COPD without evidence of previous PTB.
METHODS: Subjects with CAL identified during a Burden of Obstructive Lung Disease (BOLD) study performed in South Africa were studied. Investigations included questionnaires, lung physiology (spirometry, body plethysmography and diffusing capacity) and quantitative HRCT scans to assess bronchial anatomy and the presence of emphysema (<-950 HU), gas trapping (<-860 HU) and fibrosis (>-200 HU). Findings in subjects with a past history and/or HRCT evidence of PTB were compared with those in subjects without these features.
RESULTS: One hundred and seven of 196 eligible subjects (54.6%) were enrolled, 104 performed physiology tests and 94 had an HRCT scan. Based on history and HRCT findings, subjects were categorised as no previous PTB (NPTB, n=31), probable previous PTB (n=33) or definite previous PTB (DPTB, n=39). Subjects with DPTB had a lower diffusing capacity (Δ=-17.7%; p=0.001) and inspiratory capacity (Δ=-21.5%; p=0.001) than NPTB subjects, and higher gas-trapping and fibrosis but not emphysema scores (Δ=+6.2% (p=0.021), +0.36% (p=0.017) and +3.5% (p=0.098), respectively).
CONCLUSIONS: The mechanisms of CAL associated with previous PTB appear to differ from those in the more common smoking-related COPD and warrant further study.

Entities:  

Year:  2017        PMID: 28492127     DOI: 10.7196/SAMJ.2017.v107i5.12118

Source DB:  PubMed          Journal:  S Afr Med J


  6 in total

Review 1.  Management of chronic obstructive pulmonary disease-A position statement of the South African Thoracic Society: 2019 update.

Authors:  Mohamed Sabeer Abdool-Gaffar; Gregory Calligaro; Michelle Lianne Wong; Clifford Smith; Umesh Gangaram Lalloo; Coenraad Frederik Nicolaas Koegelenberg; Keertan Dheda; Brian William Allwood; Akhter Goolam-Mahomed; Richard Nellis van Zyl-Smit
Journal:  J Thorac Dis       Date:  2019-11       Impact factor: 2.895

2.  Burden and clinical characteristics of high grade tuberculosis destroyed lung: a nationwide study.

Authors:  Deokjae Han; Hwa Young Lee; Kyeongju Kim; Taehoon Kim; Yeon-Mok Oh; Chin Kook Rhee
Journal:  J Thorac Dis       Date:  2019-10       Impact factor: 2.895

3.  Transition from Restrictive to Obstructive Lung Function Impairment During Treatment and Follow-Up of Active Tuberculosis.

Authors:  Brian W Allwood; Elizna Maasdorp; Grace J Kim; Christopher B Cooper; Jonathan Goldin; Richard N van Zyl-Smit; Eric D Bateman; Rodney Dawson
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-05-11

4.  Assessment of lung function in successfully treated tuberculosis reveals high burden of ventilatory defects and COPD.

Authors:  Akshay N Gupte; Mandar Paradkar; Sriram Selvaraju; Kannan Thiruvengadam; Shri Vijay Bala Yogendra Shivakumar; Krithikaa Sekar; Srinivasa Marinaik; Ayesha Momin; Archana Gaikwad; Premkumar Natrajan; Munivardhan Prithivi; Gomathy Shivaramakrishnan; Neeta Pradhan; Rewa Kohli; Swapnil Raskar; Divyashri Jain; Rani Velu; Bharath Karthavarayan; Rahul Lokhande; Nishi Suryavanshi; Nikhil Gupte; Lakshmi Murali; Sundeep Salvi; William Checkley; Jonathan Golub; Robert Bollinger; Vidya Mave; Chandrasekaran Padmapriyadarasini; Amita Gupta
Journal:  PLoS One       Date:  2019-05-23       Impact factor: 3.240

5.  Chronic Obstructive Pulmonary Disease Endotypes in Low- and Middle-Income Country Settings: Precision Medicine for All.

Authors:  Trishul Siddharthan; Akshay Gupte; Peter J Barnes
Journal:  Am J Respir Crit Care Med       Date:  2020-07-15       Impact factor: 21.405

6.  Exacerbation of eosinophilic COPD and pneumonia in post-treatment pulmonary multidrug-resistant tuberculosis patient: A case report.

Authors:  Daniel Maranatha; Nur Nubli Julian Parade
Journal:  Respir Med Case Rep       Date:  2019-09-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.